MENU
RCKT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rocket Pharmaceuticals (RCKT) Earnings Date & Reports

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RCKT is expected to report earnings to fall 4.44% to -43 cents per share on March 02

Rocket Pharmaceuticals RCKT Stock Earnings Reports
Q4'25
Est.
$-0.43
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.10
The last earnings report on November 06 showed earnings per share of -44 cents, beating the estimate of -49 cents. With 1.55M shares outstanding, the current market capitalization sits at 343.06M.
View a ticker or compare two or three
RCKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RCKT showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of gene therapy services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9 Cedarbrook Drive
Phone
+1 609 659-8001
Employees
268
Web
https://www.rocketpharma.com